Massachusetts FDA-Approved Adjunctive Ketamine Therapy For Depression Announced

Thrive IV (+1-508-848-8089), the Dartmouth-based ketamine and vitamin infusion center, announces a new expansion throughout Massachusetts.

Dartmouth, United States - August 27, 2023 /PressCable/ —

Thrive IV is now offering its ketamine infusion treatments to patients at a larger scale, providing access to a solution that - when overseen by a medical professional - has been linked to alleviation of depression symptoms.

More information can be found at https://www.thriveiv.net/

Thrive IV uses carefully administered intravenous ketamine to target NMDA receptors in the brain. Research indicates that ketamine can quickly relieve depression when other treatments have failed - and significant improvement is often seen within 24 hours.

"Ketamine may be the missing puzzle piece you’ve been searching for to help make everything more clear with a path to healing your brain and feeling your best," explains a spokesperson.

Millions struggling with depression find limited results from conventional antidepressants. The clinic notes that the number of patients with TRD could be as high as 60%, based on their studies and research. This has led to a rise in patients seeking alternative solutions.

Discovered in 1962, ketamine has since been used in a range of surgical and emergency procedures across the world. It was approved by the FDA for treatment-resistant depression via nasal spray in 2019.

Though not a cure, ketamine infusion therapy has demonstrated effectiveness for managing and reducing depression symptoms in clinical trials. These studies reveal short and long-term improvements. According to the Thrive IV team, ketamine infusions have helped approximately 80% of cases with treatment-resistant depression. While more research is still needed, these promising results suggest the treatment could offer much-needed relief.

It has also been effective in treating anxiety disorders and PTSD, Thrive IV notes. With 6.8 million US adults suffering from generalized anxiety disorder and only 43% getting treatment according to the clinic, ketamine represents a safe alternative to consider - and it is well-positioned to help patients regain mental well-being.

The spokesperson adds: "We specialize in adding ketamine infusions to help increase your feeling of well-being and reduce the terrible pain, depression, or anxiety you've been experiencing. Giving you hope to live a happier and more productive, fulfilled life."

Interested parties can learn more at https://www.thriveiv.net/

Contact Info:
Name: Dr. Michael Pellegrino
Email: Send Email
Organization: Thrive IV
Address: 49 State Rd Nauset Building #102, Dartmouth, MA 02747, United States
Phone: +1-508-848-8089
Website: http://www.ThriveIV.net

Source: PressCable

Release ID: 89105949

In case of identifying any errors, concerns, or inconsistencies within the content shared in this press release that necessitate action or if you require assistance with a press release takedown, we strongly urge you to notify us promptly by contacting [email protected]. Our expert team is committed to addressing your concerns within 8 hours by taking necessary actions diligently to rectify any identified issues or supporting you with the removal process. Delivering accurate and reliable information remains our top priority.